EZH2 overexpressed in a wide variety of cancers with an active EMT [186–192] and co-operated with signal transducer and activator of transcription 3 (STAT3) to regulate MHC class I antigen processing in melanoma, which mediated immune responses [193]. Here, STAT3 is linked to cancer.